不同钙离子浓度透析液在腹膜透析患者中的应用
被引量:3
摘要
矿物质和骨代谢紊乱(MBD)是慢性肾脏病(CKD),特别是终末期肾脏病(ESRD)透析患者的常见并发症,可以导致血管钙化和心血管事件发生的危险性增加,
出处
《中华肾脏病杂志》
CAS
CSCD
北大核心
2011年第10期791-793,共3页
Chinese Journal of Nephrology
参考文献26
-
1Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002, 20, 39: 695-701.
-
2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-arteey calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342: 1478-1483.
-
3Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis, 2000, 35: 1226-1237.
-
4Moe S, Druekc T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Iut, 2006, 69: 1945-1953.
-
5Noordzij M, Korevaar JC, Bos W J, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with hacmodialysis patients. Nephrol Dial Transplant, 2006, 21: 2513-2520.
-
6Bro S, Brandi L, Daugaard H, et al. Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize? Perit Dial Int, 1997, 17: 554-559.
-
7Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis, 1996, 27: 394-401.
-
8Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int, 2004, 66: 2293-2299.
-
9Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance haemodialysis. J Am Soc Nephrol, 2004, 15: 2208-2218.
-
10Tentori F, Blayney M, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis, 2008, 52: 519- 530.
二级参考文献11
-
1De Vries JPPM, Kouw PM, van der Meer NJM. Non-invasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight. Kidney Int, 1993, 44: 851.
-
2Catherine C, Philippe M, Didier B. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia. Clin Nucl Med, 2003, 28: 467-471.
-
3Argilés A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism? Nephrol Dial Transplant, 1998, 13 Suppl 3:62-64.
-
4Palmer, Biff F. Individualizing the dialysate in the hemodialysis patient. Semin Dial, 2001, 14: 41-49.
-
5Hou SH, Zhao J, Ellman CF, et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis,1991, 2: 217-224.
-
6Argilés A, Kerr PG, Canaud B, et al. Hemodialysis and hemodiaffitration Ca kinetics, and the long-term effects of lowering dialysate calcium concentration. Kidney Int, 1993, 43: 630-640.
-
7Yudd M, Liach F. Renal osteodystrophy. In: Brenner BM, ed.Dialysis and transplantation. 北京: 科学出版社, 2001.14:259-260.
-
8Argilés A, Mion CM. Calcium balance and intact parathormone variations during haemodiafiltration. Nephrol Dial Transplant,1995, 10: 2083-2089.
-
9Femández E, Borràs M, Pais B, et al. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol, 1995, 6:132-135.
-
10Merwe WM, Rodger RS, Grant AG, et al. Low calcium dialysate and high oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients. Nephrol Dial Transplant, 1990, 5: 874-877.
共引文献50
-
1陈育青,左力,田爱辉,王党龄,孙鲁英,王梅.血液透析中超滤脱水对钙平衡的影响[J].临床内科杂志,2004,21(11):739-740. 被引量:1
-
2董捷,王梅,左力,江琪.低钙透析液及盐酸米多君对血液透析患者血压的影响[J].中华肾脏病杂志,2005,21(2):81-84.
-
3陈育青,王梅.低钙透析液对血甲状旁腺素及钙磷代谢的影响[J].肾脏病与透析肾移植杂志,2005,14(1):34-36. 被引量:30
-
4林爱武,钱家麒,庞慧华,姚强,俞赞喆,顾爱萍,张凤棣.长期使用低钙透析液对腹膜透析患者钙磷代谢的影响[J].中华肾脏病杂志,2005,21(12):713-715. 被引量:25
-
5樊瑞芬,张莉,王玉芬.透析钙曲线对血液透析中血压的影响[J].临床荟萃,2006,21(5):345-346. 被引量:2
-
6娄探奇,王成,陈珠江,彭晖,唐骅,余学清,尹培达.不同钙浓度透析液对血液透析患者钙磷代谢的影响[J].中华肾脏病杂志,2006,22(3):172-173. 被引量:3
-
7田洁,袁萍,赵继红.血液透析患者低钙透析液临床应用观察[J].中国血液净化,2006,5(2):104-105.
-
8韩晓文,李静文,杨曼.终末期肾病患者的营养管理[J].内蒙古医学杂志,2006,38(6):541-544.
-
9张增政,高妍婷,王晓玲,强华.透析液钙离子浓度对肾功能衰竭血液透析患者血清钙离子水平及血压的影响[J].现代泌尿外科杂志,2006,11(4):209-211. 被引量:5
-
10郑丹侠,朱宁,杨文领,王松,张爱华,史均宝,庄震.调整透析液钙浓度对血液透析患者血钙和甲状旁腺激素的影响[J].中国血液净化,2006,5(7):351-354. 被引量:3
同被引文献21
-
1牛欣.不同钙离子浓度透析液对血液透析患者钙平衡及分段甲状旁腺激素的影响[J].山西医药杂志(上半月),2009,38(6):560-562. 被引量:2
-
2仉超,王莹莹,张艳玲,唐晓红,秦敏.腹膜透析患者钙磷代谢紊乱临床分析[J].华西医学,2011,26(3):335-337. 被引量:4
-
3曹艳飞,麦建玲.不同钙离子浓度透析液对血液透析患者的影响[J].现代中西医结合杂志,2011,20(17):2130-2131. 被引量:4
-
4薛志强,曾石养,李小利.血液透析与腹膜透析患者钙磷代谢紊乱治疗的随访对照研究[J].中国医药导报,2011,8(30):53-57. 被引量:16
-
5赵建荣,孙德珍.腹膜透析病人的钙磷代谢紊乱[J].中国中西医结合肾病杂志,2012,13(4):355-356. 被引量:2
-
6郑设锋,卢蝉,毛红,孙维文,赵瑞育,赵章健,陈法东,缪初升,宋瑞芳,刘金女.持续质量改进对老年腹膜透析患者钙磷代谢紊乱的作用[J].中国中西医结合肾病杂志,2012,13(8):694-697. 被引量:10
-
7刘泽梅.透析液钙离子浓度对肾功能衰竭患者血液透析后血压的影响[J].吉林医学,2012,33(30):6515-6515. 被引量:1
-
8林明增,陈霄峰,范佳妮,陈文芬.腹膜透析和血液透析对尿毒症患者钙磷代谢影响的临床研究[J].中国血液净化,2013,12(9):487-490. 被引量:51
-
9王政通,丁涵露,王君如,洪大情,张月,王莉.MHD人群慢性肾脏病矿物质和骨异常单中心横断面研究[J].中国血液净化,2013,12(10):552-556. 被引量:27
-
10王荣.腹膜透析患者如何监测和调整钙磷代谢紊乱[J].肾脏病与透析肾移植杂志,2013,22(6):543-544. 被引量:9
引证文献3
-
1段思宇.不同钙离子浓度透析液预防继发性甲状旁腺功能亢进效果比较[J].现代诊断与治疗,2017,28(1):9-11.
-
2肖勇辉.探讨钙剂在腹膜透析患者中的应用指征及药学监护[J].中国现代药物应用,2017,11(9):98-99.
-
3郭志玲,常洁,贾国强,董少卿,王青苗,李楠,刘俊英,梁素忍.腹膜透析和血液透析患者CKD-MBD的现况调查及分析[J].重庆医学,2018,47(36):4637-4640. 被引量:14
二级引证文献14
-
1万峻宏.肾性贫血腹膜透析患者骨化三醇治疗后铁代谢水平[J].透析与人工器官,2022,33(3):20-22.
-
2卜玲,刘海,李婷.协同护理在腹膜透析患者中的应用研究[J].医学食疗与健康,2019,0(4):112-113.
-
3丘宝珍.碳酸镧治疗维持性血液透析患者高磷血症的疗效[J].医学信息,2019,32(24):148-150. 被引量:1
-
4阚艳红.糖尿病肾病与慢性肾小球肾炎血液透析患者血钙、血磷及全段甲状旁腺激素水平分析[J].河南医学研究,2020,29(6):1021-1022. 被引量:9
-
5何莉,黄燕林,罗怡欣,侯璐蒙,赵萍.中老年慢性肾脏病患者行透析治疗后矿物质与骨异常的发生情况及血磷异常的影响因素[J].广西医学,2020,42(8):950-953. 被引量:15
-
6黎志玲,罗建仪,曾活仪.无缝隙护理在血液透析展开急性肾功能衰竭护理中的应用及对患者肾功能的影响[J].中外医疗,2020,39(11):120-122. 被引量:2
-
7史娟娟,李晓蕾,田瑞杰,王荟苹,徐飒,苗金红.腹膜透析患者合并高磷血症的非疾病性影响因素[J].河南医学研究,2020,29(23):4251-4254.
-
8张静,陆凤清,陈吉伟.人性化护理干预在老年透析患者诱导期中的应用[J].长春中医药大学学报,2020,36(4):788-790. 被引量:10
-
9张敏,方立明,韦玲,胡泳,谢圣芳.维持性腹膜透析患者矿物质代谢达标情况分析[J].吉林医学,2021,42(5):1062-1064.
-
10程丽慧,陈兴强,林丽娟,陈洁,龙作鹏.慢性肾衰竭血液透析并发高磷血症患者的生活质量状况及其影响因素[J].国际泌尿系统杂志,2021,41(3):531-534. 被引量:15
-
1曹艳飞,麦建玲.不同钙离子浓度透析液对血液透析患者的影响[J].现代中西医结合杂志,2011,20(17):2130-2131. 被引量:4
-
2匡彬,方倩瑜,陈少敬,沈彩英,陈建繁.不同钙离子浓度透析液预防继发性甲状旁腺功能亢进效果比较[J].山东医药,2016,56(2):76-77. 被引量:7
-
3章圣泽,董芍芍,杨群伟,朱源,周志宏.低钙透析对伴有高血压的血液透析患者血压的影响[J].全科医学临床与教育,2007,5(2):154-155. 被引量:3
-
4汪延辉,刘毅,徐玉兰,郑尘非,王绿萍,梅晓蓉.低钙透析液对维持性血液透析伴有高血钙患者的疗效观察[J].浙江医学,2007,29(10):1089-1090.
-
5陈红艳,黄柏勇.120例维持性血液透析患者维生素D水平及相关因素分析[J].实用医药杂志,2015,32(10):912-913. 被引量:1
-
6牛欣.不同钙离子浓度透析液对血液透析患者钙平衡及分段甲状旁腺激素的影响[J].山西医药杂志(上半月),2009,38(6):560-562. 被引量:2
-
7谢庆军,周静文,吴卓媚,李科慧,周红卫,谢恺庆.维持性血液透析患者矿物质和骨代谢紊乱与血清hs-CRP水平的关系[J].山东医药,2016,56(45):31-33. 被引量:14
-
8朱国红,张毅华,陈晓泓.护理指导对维持性血液透析患者并发疼痛的作用[J].上海护理,2016,16(3):57-58. 被引量:8
-
9靳政玺,张菁,王红梅,陈强.不同透析方法对维持性血液透析患者骨代谢紊乱及成纤维细胞生长因子-23的影响[J].山西医药杂志,2016,45(2):170-173. 被引量:4
-
10王成,娄探奇,陈珠江,唐骅,石成钢,余学清,尹培达.长期应用不同钙离子浓度透析液对血液透析患者血压影响的对照研究[J].中国危重病急救医学,2007,19(4):236-238. 被引量:6